Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial
Michael J. Corley(Cornell University), Steven Grinspoon(Massachusetts General Hospital), Heather J. Ribaudo(Cancer Research And Biostatistics), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Sarah M Chu(Harvard University), Alan Landay(The University of Texas Medical Branch at Galveston), Alina P.S. Pang(Institute on Aging), María Saumoy(Bellvitge University Hospital), Ryan Smith, Wadzanai Samaneka(University of Zimbabwe), Pamela S. Douglas(Duke University), Sonal S. Munsiff(University of Rochester), Michael T. Lu(Cancer Research And Biostatistics), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Marissa R Diggs(Harvard University), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Sara McCallum(Cancer Research And Biostatistics), Varun B. Dwaraka(Cytodiagnostics (Canada)), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Markella V. Zanni(Harvard University), Maya Watanabe(Cancer Research And Biostatistics), Kristine M. Erlandson(University of Colorado Denver)
Cited by 8
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
|Nature Medicine|2006|3.6k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k